Arno Therapeutics Overview

  • Year Founded
  • 2005

Year Founded

  • Status
  • Public

  • Employees
  • 4

Employees

  • Stock Symbol
  • ARNI

Stock Symbol

  • Investments
  • 1

Arno Therapeutics General Information

Description

Arno Therapeutics Inc operates as a biopharmaceutical company. It develops drug candidates to treat patients with cancer and other life-threatening diseases. It develops pre-clinical and clinical-stage products under the following names: Onapristone, AR-42, and AR-12. Onapristone is indicated for endometrial, prostate, and breast cancer indications; AR-42 is provided for hematological malignancies and solid tumor indications; and AR-12 is offered for solid tumors and hematological malignancies, and various anti-microbial targets.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 200 Route 31 North
  • Suite 104
  • Flemington, NJ 08822
  • United States
+1 (862)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Stock Exchange
OTCM
Vertical(s)
Corporate Office
  • 200 Route 31 North
  • Suite 104
  • Flemington, NJ 08822
  • United States
+1 (862)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Arno Therapeutics Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
3.5K

Arno Therapeutics Financials Summary

As of 30-Sep-2016, Arno Therapeutics has a trailing 12-month revenue of null.

In Thousands,
USD
TTM 30-Sep-2016 FY 2015 31-Dec-2015 FY 2014 31-Dec-2014 FY 2013 31-Dec-2013
EV 18,603 6,927 2,036 60,199
Revenue 0
EBITDA (13,650) (11,480) 7,742 (21,092)
Net Income (13,695) (11,508) 7,771 (39,657)
Total Assets 2,356 361 8,248 26,883
Total Debt 5 2,098 11 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Arno Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Arno Therapeutics‘s full profile, request access.

Request a free trial

Arno Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Arno Therapeutics Inc operates as a biopharmaceutical company. It develops drug candidates to treat patients with cancer
Drug Discovery
Flemington, NJ
4 As of 2016

Boston, MA
 

Cambridge, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Arno Therapeutics Competitors (10)

One of Arno Therapeutics’s 10 competitors is Vertex Pharmaceuticals, a Formerly VC-backed company based in Boston, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Vertex Pharmaceuticals Formerly VC-backed Boston, MA
Sarepta Therapeutics Formerly VC-backed Cambridge, MA
Cristal Therapeutics Venture Capital-Backed Maastricht, Netherlands
Aura Biosciences Formerly VC-backed Boston, MA
Spark Therapeutics Formerly VC-backed Philadelphia, PA
You’re viewing 5 of 10 competitors. Get the full list »

Arno Therapeutics Patents

Arno Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-11613555-B2 Methods for onapristone synthesis dehydration and deprotection Active 30-Nov-2016
US-20180148471-A1 Methods for onapristone synthesis dehydration and deprotection Inactive 30-Nov-2016
US-20210221838-A1 Methods for onapristone synthesis dehydration and deprotection Active 30-Nov-2016
WO-2018102369-A1 Methods for onapristone synthesis dehydration and deprotection Inactive 30-Nov-2016
WO-2017165315-A1 Onapristone metabolite compositions and methods Inactive 21-Mar-2016 A61K31/575
To view Arno Therapeutics’s complete patent history, request access »

Arno Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Arno Therapeutics Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Arno Therapeutics‘s full profile, request access.

Request a free trial

Arno Therapeutics Acquisitions (1)

Arno Therapeutics’s most recent deal was a Merger/Acquisition with Laurier International. The deal was made on 04-Jun-2008.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Laurier International 04-Jun-2008 Merger/Acquisition Special Purpose Acquisition Company (SPAC)
To view Arno Therapeutics’s complete acquisitions history, request access »

Arno Therapeutics FAQs

  • When was Arno Therapeutics founded?

    Arno Therapeutics was founded in 2005.

  • Where is Arno Therapeutics headquartered?

    Arno Therapeutics is headquartered in Flemington, NJ.

  • What is the size of Arno Therapeutics?

    Arno Therapeutics has 4 total employees.

  • What industry is Arno Therapeutics in?

    Arno Therapeutics’s primary industry is Drug Discovery.

  • Is Arno Therapeutics a private or public company?

    Arno Therapeutics is a Public company.

  • What is Arno Therapeutics’s stock symbol?

    The ticker symbol for Arno Therapeutics is ARNI.

  • Who are Arno Therapeutics’s competitors?

    Vertex Pharmaceuticals, Sarepta Therapeutics, Cristal Therapeutics, Aura Biosciences, and Spark Therapeutics are some of the 10 competitors of Arno Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process